Uroplasty Revenue Quarterly YoY Growth:
4.61% for Dec. 31, 2012Uroplasty Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 4.61% |
| Sept. 30, 2012 | 14.94% |
| June 30, 2012 | 19.86% |
| March 31, 2012 | 39.41% |
| Dec. 31, 2011 | 53.04% |
| Sept. 30, 2011 | 53.09% |
| June 30, 2011 | 53.29% |
| March 31, 2011 | 34.60% |
| Dec. 31, 2010 | 13.82% |
| Sept. 30, 2010 | 8.65% |
| June 30, 2010 | 7.42% |
| March 31, 2010 | 2.54% |
| Dec. 31, 2009 | -9.42% |
| Sept. 30, 2009 | -23.82% |
| June 30, 2009 | -37.56% |
| March 31, 2009 | -29.71% |
| Dec. 31, 2008 | -9.17% |
| Sept. 30, 2008 | 28.98% |
| June 30, 2008 | 53.48% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
UPI Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Abiomed | 16.95% |
| Guided Therapeutics | 9.88% |
| Smith & Nephew | -0.37% |
UPI Revenue Quarterly YoY Growth Rankings
| Overall |
69th percentile 2351 of 7590 |
| Sector |
59th percentile 264 of 651 in Healthcare |
| Industry |
54th percentile 41 of 90 in Medical Devices |
UPI Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -37.56% | Jun 2009 |
| Maximum | 53.48% | Jun 2008 |
| Average | 14.63% |
